by katehumphrey | Mar 27, 2024 3:15 pm | Biotechnology, Private Equity
Highbridge Capital Management, based in New York City, announced on March 27 that it entered into an agreement to acquire Gamida Cell, an Israeli biotechnology company. The agreement will see Highbridge Capital Management convert $75 million of existing... Read More »
by katehumphrey | Mar 26, 2024 1:45 pm | Laboratories, MRI & Dialysis, Private Equity
McKinney, Texas-based StatLab Medical Products announced that it has acquired Poly Scientific R&D. Poly Scientific is one of the leading manufacturers of chemicals, stains and reagents for histology, cytology and microbiology, as well as other items for... Read More »
by katehumphrey | Mar 26, 2024 1:44 pm | Pharmaceuticals
On March 26, Juvisé Pharmaceuticals announced that it entered into an agreement to acquire the global rights to PONVORY from Actelion Pharmaceuticals, a Johnson & Johnson company. These global rights exclude the rights to United States and Canada. Ponvory is... Read More »
by katehumphrey | Mar 25, 2024 3:12 pm | Physician Medical Groups
Trinity Health Michigan has entered into an agreement to acquire West Michigan Rheumatology, a three-provider practice. Based in Grand Rapids, Michigan, West Michigan Rheumatology has provided care to patients suffering from a variety of rheumatological... Read More »
by katehumphrey | Mar 25, 2024 1:52 pm | Biotechnology
On March 25, Chicago-based AbbVie Inc. announced that it entered into an agreement to acquire Landos Biopharma for $137.5 million. AbbVie will acquire Landos at a price of $20.42 per share in cash upon closing, plus one non-tradable contingent value right per... Read More »